Fertility hormone testing often sounds more definitive than it really is. Many people hope a blood panel will answer the biggest question at once: Can I get pregnant, and how much time do I have? In practice, these tests are useful, but each one measures only part of the story. AMH helps estimate ovarian reserve. FSH, LH, and estradiol are most meaningful when matched to the right point in the cycle. Progesterone is mainly used to show whether ovulation likely happened. None of them, alone or together, can fully capture egg quality, tubal health, sperm factors, implantation, or the chance of natural conception in a given month.
That is why timing and interpretation matter so much. A normal result can still sit beside infertility, and an abnormal result does not always mean pregnancy is impossible. This guide explains what each fertility hormone test measures, when to draw it, what results can and cannot tell you, and how clinicians use patterns rather than single numbers to make decisions.
Quick Overview
- Fertility hormone testing can clarify ovulation patterns, ovarian reserve, and cycle function, but it does not replace semen testing or tubal evaluation.
- AMH is most helpful for estimating ovarian reserve and predicting response to stimulation, not for predicting natural pregnancy on its own.
- FSH, LH, and estradiol are easiest to interpret early in the cycle, while progesterone is most useful about 7 days after ovulation.
- A mistimed test can be more misleading than a mildly abnormal one.
- If cycles are irregular, ask for a testing plan tied to your actual ovulation pattern rather than a one-size-fits-all “day 3 and day 21” approach.
Table of Contents
- What These Tests Show
- Timing Changes Everything
- AMH and Ovarian Reserve
- Reading FSH, LH, and Estradiol
- What Progesterone Confirms
- Patterns and Next Steps
What These Tests Show
Fertility hormone testing is best understood as a set of clues, not a final verdict. Each hormone gives a different type of information, and the most accurate interpretation comes from seeing how those clues fit together with age, cycle history, ultrasound findings, semen results, and any symptoms such as irregular bleeding, acne, missed periods, pelvic pain, or hot flashes.
AMH, or anti-Müllerian hormone, is usually treated as an ovarian reserve marker. It reflects the pool of small growing follicles in the ovaries and is often used to estimate how the ovaries might respond to stimulation during fertility treatment. It is helpful, but it does not directly measure whether an egg will fertilize, implant, or lead to a live birth.
FSH, or follicle-stimulating hormone, is one of the brain-to-ovary signals that helps recruit follicles early in the menstrual cycle. Estradiol, the main estrogen measured in fertility workups, is produced by developing follicles. LH, or luteinizing hormone, helps trigger ovulation. Progesterone rises after ovulation, when the corpus luteum forms. Put simply, AMH is mostly about reserve, FSH and estradiol are about early-cycle recruitment and ovarian feedback, LH is about ovulatory signaling, and progesterone is about what happened after ovulation.
That sounds tidy, but clinical reality is less neat. These tests do not answer several major fertility questions on their own:
- whether the fallopian tubes are open
- whether sperm count and motility are normal
- whether the uterus has a cavity problem
- whether embryos are genetically normal
- whether intercourse or insemination is timed well
- whether implantation will succeed
This is why a “normal hormone panel” should never be read as proof that fertility is normal, and an “abnormal hormone panel” should not be read as proof that pregnancy cannot happen.
There is also an important distinction between ovarian reserve and fertility potential. Ovarian reserve is mostly about egg quantity. Fertility potential also depends on egg quality, which is more tightly linked to age than to any single hormone result. A younger person with low AMH may still conceive naturally. A person with normal AMH at 40 may still struggle because egg quality has declined even if follicle count looks acceptable.
Clinicians therefore use these tests for specific purposes:
- to assess ovarian reserve
- to look for evidence of ovulation or lack of ovulation
- to help evaluate irregular or absent periods
- to identify patterns that suggest PCOS, hypothalamic suppression, or ovarian insufficiency
- to guide fertility-treatment planning
The key mindset is that hormone testing is most valuable when the question is clear. “Why are my periods irregular?” and “Did I ovulate this cycle?” are better testing questions than “Tell me everything about my fertility.” The more precise the question, the more useful the hormone panel becomes.
Timing Changes Everything
One of the biggest reasons fertility hormone testing gets misread is that hormones are dynamic. They rise and fall across the cycle, and the same number can mean very different things depending on when it was drawn. A result is not just a value. It is a value plus a date in the cycle.
AMH is the least timing-sensitive of the group. It can usually be drawn on any cycle day, which makes it the most convenient marker in fertility workups. Even so, “any day” does not mean “any context.” Hormonal contraception, recent pregnancy, ovarian surgery, and some medical treatments can influence interpretation.
FSH, LH, and estradiol are usually checked in the early follicular phase, often around cycle days 2 to 4. That is when baseline ovarian signaling is easiest to compare from one person to another. Testing them later in the cycle, when follicles are already growing or ovulation is approaching, can create a completely different picture and lead to false conclusions about reserve or ovulatory function.
Progesterone is the hormone most often mistimed. Many people are told to get a “day 21 progesterone,” but that only fits a textbook 28-day cycle with ovulation around day 14. The more accurate rule is to check progesterone about 7 days after ovulation, not automatically on day 21. For a 35-day cycle, that may be closer to day 28. For irregular cycles, the timing may need to be based on LH surge testing, basal body temperature, ultrasound monitoring, or careful symptom tracking.
This is where fertility testing often falls apart in real life. Someone with irregular cycles gets a day 21 progesterone drawn, the result is low, and the conclusion becomes “you did not ovulate.” But if ovulation had not happened yet, the result was answering the wrong question on the wrong day.
A practical timing summary looks like this:
- AMH: often any cycle day
- FSH, LH, estradiol: usually early follicular phase, around days 2 to 4
- Progesterone: about 7 days after ovulation
- Pregnancy testing: whenever there is cycle delay or luteal uncertainty
Timing matters even more if cycles are absent, very long, or unpredictable. In those cases, a rigid calendar approach is often less useful than a symptom-based or ultrasound-guided plan. People with prolonged gaps between periods often need a broader workup that goes beyond the standard fertility hormones and may include prolactin, thyroid testing, androgen labs, or imaging. If that pattern sounds familiar, a review of common causes of missed periods and amenorrhea can help explain why the workup expands.
The main lesson is simple: a well-timed test can be highly informative, while a poorly timed test can create false alarm, false reassurance, or both. Before interpreting any result, ask two questions: What day of the cycle was this, and what clinical question was the test trying to answer?
AMH and Ovarian Reserve
AMH is often the first fertility hormone people hear about, and it is also the one most likely to be overinterpreted. AMH is produced by small follicles in the ovaries and is used mainly as a marker of ovarian reserve, which is essentially an estimate of egg quantity rather than egg quality.
That distinction matters. A lower AMH suggests fewer recruitable follicles, not necessarily worse eggs in every remaining follicle. Age still carries more information about egg quality and chromosomal risk than AMH alone. This is why AMH can be emotionally loaded: people often treat it like a fertility score when it is really one part of a broader assessment.
Clinically, AMH is especially useful in three ways:
- estimating ovarian reserve
- anticipating response to ovarian stimulation in IVF or egg freezing
- helping interpret patterns such as very high reserve in PCOS or reduced reserve after surgery, chemotherapy, or ovarian injury
AMH is less useful as a direct predictor of spontaneous pregnancy in a person trying naturally. A lower result may signal reduced reserve, but it does not prove natural conception is unlikely in the short term. A normal or high result does not guarantee easy conception either, because tubal disease, male factor infertility, endometriosis, and implantation issues can still dominate the picture.
A few common AMH misunderstandings are worth clearing up.
Low AMH does not mean zero chance.
People often panic when AMH is described as low for age. In reality, it may mean time matters more, treatment planning deserves attention, or ovarian response to stimulation could be lower than average. It does not automatically mean pregnancy is impossible.
High AMH is not automatically good news.
Very high AMH can be seen in people with PCOS, where follicle count is high but ovulation may be infrequent or absent. In IVF planning, very high AMH can also raise concern about over-response to stimulation.
AMH is not a menopause clock.
It declines with reproductive aging, but it cannot predict the exact month or year pregnancy will stop being possible.
AMH is not the primary test for ovarian insufficiency.
If someone under 40 has missed or very irregular periods plus symptoms of estrogen deficiency, FSH and estradiol usually carry more immediate diagnostic weight. AMH can add context, but it is not the main rule-in or rule-out test in that setting. When that pattern is under discussion, a guide to premature ovarian insufficiency helps frame what low reserve markers do and do not mean.
AMH works best when paired with context:
- age
- menstrual regularity
- antral follicle count on ultrasound
- ovarian surgery history
- chemotherapy exposure
- hormonal contraception use
- family history of early menopause or ovarian insufficiency
If AMH has one core message, it is this: it is a useful reserve marker and a strong treatment-planning tool, but it is not a single-number prediction of who will or will not get pregnant.
Reading FSH, LH, and Estradiol
FSH, LH, and estradiol are often ordered together because they describe a conversation between the brain and the ovaries. FSH and LH come from the pituitary. Estradiol comes mainly from ovarian follicles. Reading them as a group is more useful than reading any one in isolation.
Early in the cycle, FSH helps recruit follicles. If the ovaries are becoming less responsive, the brain may need to push harder, and baseline FSH can rise. That is why a higher early-follicular FSH may suggest reduced ovarian reserve. But there is an important catch: estradiol can suppress FSH. If early-cycle estradiol is already somewhat elevated, FSH may appear deceptively “normal.” That is why clinicians often look at day 2 to 4 FSH and estradiol together instead of treating FSH as a stand-alone test.
Estradiol itself is not usually used as a solo reserve test. A low estradiol can fit a quiet early cycle. A higher early estradiol can reflect a follicle already recruiting earlier than expected, which may make FSH less reliable that month. Later in the cycle, estradiol rises normally as follicles mature, so timing is everything.
LH is the hormone people know from ovulation predictor kits, and that is often where it is most practical. A surge in LH helps trigger ovulation. In blood testing, however, a single LH value can be difficult to interpret unless the timing is clear. Baseline LH is not a universal fertility marker, and one isolated result rarely answers much on its own.
LH becomes more interesting in patterns such as suspected PCOS, where LH may be relatively elevated compared with FSH. Even there, the old idea that an LH-to-FSH ratio alone diagnoses PCOS is too simplistic. PCOS is a clinical syndrome, not a ratio. Symptoms, cycle history, androgen signs, ultrasound findings, and metabolic features matter more than one formula. If irregular cycles, acne, or excess hair growth are part of the picture, this overview of common PCOS symptoms helps put the lab pattern into context.
A practical way to think about these three hormones is:
- FSH asks how hard the pituitary needs to work early in the cycle
- Estradiol shows what the developing follicles are producing
- LH helps identify the shift toward ovulation and, in some patterns, broader ovulatory dysfunction
Patterns that raise specific questions include:
- high FSH with low estradiol in a younger person with missed periods
- apparently normal FSH with unexpectedly elevated early estradiol
- high LH with irregular cycles and androgen-related symptoms
- low or normal gonadotropins with absent periods, suggesting hypothalamic or pituitary suppression rather than primary ovarian failure
These tests are useful, but only when they are placed in the right time window and interpreted as physiology rather than as isolated flags. A fertility workup becomes more accurate when the question changes from “Is this number normal?” to “What is the ovaries-to-brain conversation doing this cycle?”
What Progesterone Confirms
Progesterone is the test most often used to answer a specific fertility question: Did ovulation likely occur? After an egg is released, the corpus luteum forms and begins producing progesterone. That rise helps transform the uterine lining into a more receptive state for implantation. Because of that physiology, midluteal progesterone is often used as a biochemical sign that ovulation probably happened.
The most important word in that sentence is probably. Progesterone is useful, but it is not perfect.
A single midluteal progesterone value is often enough to support that ovulation occurred in that cycle. What it does much less well is diagnose every cause of infertility or establish that the luteal phase is “strong enough” in a precise way. Progesterone is pulsatile and can fluctuate meaningfully even within the same day. That is one reason why a single borderline result should be interpreted cautiously rather than treated like a final judgment on implantation potential.
This is also where the “day 21 progesterone” shortcut creates confusion. Progesterone should be checked roughly 7 days after ovulation:
- about day 21 in a 28-day cycle
- later in longer cycles
- based on LH surge or ovulation tracking if cycles are variable
If the blood draw is too early, progesterone may look low simply because ovulation has not happened yet. If it is too late, the value may already be falling.
A few practical uses of progesterone include:
- confirming likely ovulation in natural cycles
- checking timing in fertility tracking
- helping investigate irregular cycles or suspected anovulation
- supporting treatment planning in ovulation-induction cycles
What progesterone does not do especially well on its own:
- prove the uterine lining is fully receptive
- diagnose luteal phase deficiency with high certainty
- explain repeated failed conception without other findings
- replace ultrasound or more complete ovulation assessment when the timing is unclear
This last point matters because luteal phase deficiency is one of the most debated ideas in reproductive endocrinology. A low midluteal progesterone can reflect mistiming, cycle variability, or transient physiology rather than a stable defect that clearly explains infertility.
In everyday fertility work, progesterone is most helpful when paired with the right question and the right timing. If you are tracking cervical mucus, ovulation pain, temperature shift, or a positive urine LH surge, progesterone can act as a biochemical confirmation of the same story. If you are not sure when ovulation happens, that uncertainty has to be solved first. A primer on signs of ovulation can make midluteal testing much easier to time correctly.
The best way to think about progesterone is as a confirmation tool, not a master fertility test. It is excellent for asking whether ovulation likely occurred. It is far less reliable for explaining every failure to conceive.
Patterns and Next Steps
The most useful fertility hormone interpretation happens at the pattern level. Clinicians rarely make decisions from AMH, FSH, LH, estradiol, or progesterone alone. They look for combinations that point in a direction.
For example:
- Low AMH with elevated early-cycle FSH may suggest reduced ovarian reserve, especially if age or antral follicle count points the same way.
- High LH with irregular cycles and signs of androgen excess may fit an ovulatory disorder such as PCOS rather than a primary ovarian reserve problem.
- Low or normal FSH and LH with low estradiol and absent periods may suggest hypothalamic or pituitary suppression, particularly after major weight loss, overtraining, illness, or stress.
- Repeatedly high FSH with low estradiol in someone under 40 raises concern for premature ovarian insufficiency and usually deserves repeat confirmation and broader evaluation.
- Normal hormones with no pregnancy after appropriate time trying may mean the key issue lies elsewhere, such as sperm, tubes, endometriosis, uterine factors, or timing.
This is also where age and duration of trying matter. In general, evaluation is often recommended after 12 months of regular unprotected intercourse if the woman is under 35, and after 6 months if she is 35 or older. Earlier evaluation may make sense when cycles are clearly irregular, periods are absent, there is known endometriosis, prior pelvic infection, prior chemotherapy, or a history that already suggests ovulatory or ovarian problems.
A good fertility workup therefore expands beyond this hormone panel when needed. Common additions may include:
- pelvic ultrasound and antral follicle count
- semen analysis
- thyroid and prolactin testing when cycles are abnormal
- androgen testing when PCOS or other hyperandrogenic states are suspected
- tubal and uterine evaluation
- repeat testing when a result does not fit the clinical picture
This broader view prevents two common mistakes. The first is overreacting to one abnormal lab. The second is stopping too early after “normal” hormone results.
The next step after hormone testing should depend on the pattern:
- confirm timing
- compare the result with symptoms and cycle history
- decide whether the main question is reserve, ovulation, ovarian insufficiency, or something outside the hormone panel
- add semen, ultrasound, or tubal evaluation when the picture is incomplete
If the pattern suggests more than routine cycle variation, or if age and time are becoming more important, a specialist review may be appropriate. That is especially true when there are missed periods, suspected ovarian insufficiency, suspected pituitary disease, or repeated abnormal results that do not fit a simple explanation. When the threshold for referral is unclear, this guide to when specialist endocrine input may help can clarify what deserves faster follow-up.
The bottom line is that fertility hormone testing is powerful when it is used as part of a map. AMH, FSH, LH, estradiol, and progesterone each mark different landmarks. The real answer comes from seeing the whole route, not from staring at one point on the page.
References
- Fertility evaluation of infertile women: a committee opinion 2021 (Committee Opinion)
- Diagnosis and treatment of luteal phase deficiency: a committee opinion 2021 (Committee Opinion)
- Anti-Müllerian hormone for screening, diagnosis, evaluation, and prediction: A systematic review and expert opinions 2024 (Systematic Review)
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (Guideline)
- Evidence-based guideline: Premature Ovarian Insufficiency 2025 (Guideline)
Disclaimer
This article is for educational purposes only and is not a substitute for personal medical advice, diagnosis, or treatment. Fertility hormone tests must be interpreted in clinical context, including age, cycle timing, symptoms, ultrasound findings, semen testing, and any history of irregular periods, pregnancy loss, surgery, chemotherapy, or endocrine disease. A low or high hormone result does not, by itself, confirm infertility or predict whether pregnancy is impossible or guaranteed.
If this article clarified a confusing part of fertility testing, consider sharing it on Facebook, X, or another platform so more people can understand what these hormone results really do and do not mean.
